References
- Alayed, N., et al., 2014. Sickle cell disease and pregnancy outcomes: population-based study on 8.8 million births. Journal of Perinatal Medicine, 42 (4), 487–492.
- Anyaegbunam, A., et al., 1994. Placental histology and placental/fetal weight ratios in pregnant women with sickle cell disease: relationship to pregnancy outcome. Journal of the Association for Academic Minority Physicians, 5 (3), 123–125.
- Asare, E., et al., 2018. A case series describing causes of death in pregnant women with sickle cell disease in a low-resource setting. American Journal of Hematology, 93 (7), E167–E170.
- Asnani, M., McCaw-Binns, A., and Reid, M., 2011. Excess risk of maternal death from sickle cell disease in Jamaica: 1998–2007. PLOS One, 6 (10), e26281.
- Boafor, T., et al., 2016. Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis. British Journal of Gynecology, 123 (5), 691–698.
- Darnal, N. and Dangal, G., 2020. Maternal and fetal outcome in emergency versus elective caesarean section. Journal of Nepal Health Research Council, 18 (2), 186–189.
- Della-Moretta, S., et al., 2021. Risk factors for adverse maternal and fetal outcomes in pregnant patients with sickle cell disease. Blood, 138 (Suppl. 1), 3117.
- Deneux-Tharaux, C., et al., 2006. Postpartum maternal mortality and cesarean delivery. Obstetrics and Gynecology, 108 (3 Pt 1), 541–548.
- Endler, M., Saltvedt, S., and Papadogiannakis, N., 2016. Macroscopic and histological characteristics of retained placenta: a prospectively collected case-control study. Placenta, 41, 39–44.
- Fisch, S., et al., 2021. Pregnancy outcomes in women with sickle cell disease in California: a retrospective cohort study. Blood, 138 (Suppl. 1), 489.
- Galiba Atipo Tsiba, F., et al., 2020. Pregnancy outcomes among patients with sickle cell disease in Brazzaville. Anemia, 2020, 1989134.
- Kopeika, J., et al., 2019. Ovarian reserve in women with sickle cell disease. PLOS One, 14 (2), e0213024.
- Kuo, K. and Caughey, A., 2016. Contemporary outcomes of sickle cell disease in pregnancy. American Journal of Obstetrics and Gynecology, 215 (4), 505.e1–505.e5.
- Lari, N., DeBaun, M., and Oppong, S., 2017. The emerging challenge of optimal blood pressure management and hypertensive syndromes in pregnant women with sickle cell disease: a review. Expert Review of Hematology, 10 (11), 987–994.
- Lewis, G., et al., 2021. Pregnancy outcome in homozygous sickle cell disease: observations from the Jamaican Birth Cohort. British Journal of Gynecology, 128 (10), 1703–1710.
- Mahadik, K., 2019. Rising cesarean rates: are primary sections overused? Journal of Obstetrics and Gynaecology of India, 69 (6), 483–489.
- McCaw-Binns, A., Campbell, L., and Spence, S., 2018. The evolving contribution of non-communicable diseases to maternal mortality in Jamaica, 1998–2015: a population-based study. British Journal of Gynecology, 125 (10), 1254–1261.
- Noubiap, J., et al., 2018. Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis. Thrombosis Journal, 16 (1), 27.
- Omotayo, M., et al., 2021. Prenatal anemia and postpartum hemorrhage risk: a systematic review and meta‐analysis. Journal of Obstetrics and Gynaecology Research, 47 (8), 2565–2576.
- Oppong, S., et al., 2019. Multidisciplinary care results in similar maternal and perinatal mortality rates for women with and without SCD in a low-resource setting. American Journal of Hematology, 94 (2), 223–230.
- Oteng-Ntim, E., et al., 2015. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis. Blood, 125 (21), 3316–3325.
- Patel, V. and Ibrahim, I., 2021. Sickle cell disease bias: an early opportunity for intervention? Blood, 138 (Suppl. 1), 4947.
- Serjeant, G., et al., 2004. Outcome of pregnancy in homozygous sickle cell disease. Obstetrics and Gynecology, 103 (6), 1278–1285.
- Sun, P., et al., 2001. Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia. American Journal of Obstetrics and Gynecology, 184 (6), 1127–1130.
- Simms-Stewart, D., et al., 2009. Retained placenta in homozygous sickle cell disease. Obstetrics and Gynecology, 114 (4), 825–828.
- Swarray‐Deen, A., et al., 2020. Cerebro‐placental ratio as a prognostic factor of fetal outcome in pregnancy complicated by maternal sickle cell disease. International Journal of Gynaecology and Obstetrics, 150 (2), 248–253.
- Trotman, H., et al., 2021. Neonatal mortality in the 2011 JAKIDS birth cohort. Psychology, Health & Medicine, 1–9.
- Villers, M., et al., 2008. Morbidity associated with sickle cell disease in pregnancy. American Journal of Obstetrics and Gynecology, 199 (2), 125.e1–125.e5.
- Wilson, N., et al., 2012. Pregnancy outcomes among patients with sickle cell disease at Korle-Bu Teaching Hospital, Accra, Ghana: retrospective cohort study. American Journal of Tropical Medicine and Hygiene, 86 (6), 936–942.